• STADA acquires LEO Pharma existing FITO trademark in the GCC, North Africa, the Middle East and selected Asian Countries.
• STADA EVP Emerging Markets Stephane Jacqmin: “We look forward to leveraging our local marketing and sales platform to develop the full potential of this strong brand in the many markets of the MENA region. This will strengthen STADA’s role as the partner of choice in consumer healthcare and support our growth in this region”

Dubai12August2024 – The pharmaceutical company STADA is expanding its consumer healthcare business in the MENA region with the acquisition of FITO™ from LEO Pharma. The medical device is based on the wheat extract Rigenase (DamorFarmaceutici, Italy) and is indicated for the dermatological treatment of first- and second-degree burns, ulcers, wounds and abrasions. The herbal origin has a high safety profileand forms a protective barrier against the external environment.

Continue reading STADA acquires FITO™ from LEO Pharma and expands Consumer Healthcare in the MENA Region →